Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification of a novel activated form of the keratinocyte growth factor receptor by expression cloning from parathyroid adenoma tissue

Abstract

Parathyroid adenomas are benign tumors in the parathyroid glands, whose pathogenesis is largely unknown. We utilized an expression cDNA cloning strategy to identify oncogenes activated in parathyroid adenomas. An expression cDNA library was prepared directly from a clinical sample of parathyroid adenoma tissue, transfected into NIH3T3 cells, and foci of morphologically transformed cells were isolated. Following plasmid rescue, we identified cDNAs for the keratinocyte growth factor receptor at a high frequency. Interestingly, approximately half of the clones encoded a variant receptor containing an altered C-terminus. Analysis of the transforming activity of the variant receptor revealed that the altered C-terminus up-regulated the transforming activity in a ligand-independent manner. The higher transforming activity was not accompanied by increase of dimerization or overall autophosphorylation of the receptor. However, tyrosine phosphorylation of downstream receptor substrates, including Shc isoforms and possibly FRS2, are increased in the transfectants expressing the parathyroid tumor-derived receptor. Genomic analysis showed that a previously unidentified exon was used to form the novel isoform. This alternative splicing appears to occur preferentially in parathyroid adenomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima R, Byers MG, Shows TB and Kronenberg HM. . 1989 J. Clin. Invest. 83: 2034–2040.

  • Bilezikian JP. . 1993 In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Favus MJ. (ed.) Raven Press: New York pp. 155–159.

    Google Scholar 

  • Chan AML, McGovern ES, Catalano G, Fleming TP and Miki T. . 1994 Oncogene 9: 1057–1063.

  • Finch PW, Rubin JS, Miki T, Ron D and Aaronson SA. . 1989 Science 245: 752–755.

  • Hattori Y, Odagiri H, Nakatani H, Miyagawa K, Naito K, Sakamoto H, Katoh O, Yoshida T, Sugimura T and Terada M. . 1990 Proc. Natl. Acad. Sci. USA 87: 5983–5987.

  • Itoh H, Hattori Y, Sakamoto H, Ishii H, Kishi T, Sasaki H, Yoshida T, Koono M, Sugimura T and Terada M. . 1994 Cancer Res. 54: 3237–3241.

  • Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J. . 1997 Cell 89: 693–702.

  • Lorenzi MV, Castagnino P, Chen Q, Chedid M and Miki T. . 1997 Oncogene 15: 817–826.

  • Lorenzi MV, Horii Y, Yamanaka R, Sakaguchi K and Miki T. . 1996 Proc. Natl. Acad. Sci. USA 93: 8956–8961.

  • Lorenzi MV, Castagnino P, Chen Q, Hori Y and Miki T. . 1999 Oncogene in press.

  • Miki T and Aaronson SA. . 1993 In: Methods in Molecular Genetics, Vol. 1. Academic Press: Orlando pp. 3–22.

    Google Scholar 

  • Miki T and Aaronson SA. . 1995 In: Oncogene Techniques, Vol. 254: Methods in Enzymology. Vogt PK and Verma IM. (eds).. Academic Press: New York pp. 196–206.

    Google Scholar 

  • Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM-L and Aaronson SA. . 1992 Proc. Natl. Acad. Sci. USA 89: 246–250.

  • Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D and Aaronson SA. . 1991a Science 251: 72–75.

  • Miki T, Fleming TP, Crescenzi M, Molloy CJ, Blam SB, Reynolds SH and Aaronson SA. . 1991b Proc. Natl. Acad. Sci. USA 88: 5167–5171.

  • Miki T, Smith CL, Long JE, Eva A and Fleming TP. . 1993 Nature 362: 462–465.

  • Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M and Schlessinger J. . 1992 Nature 358: 681–684.

  • Peters KG, Marie J, Wilson E, Ives HE, Escobedo J, Rosario MD, Mirda D and Williams LT. . 1992 Nature 358: 678–681.

  • Sawyers CL and Denny CT. . 1994 Cell 77: 171–173.

  • Takagi Y, Shrivastav S, Miki T and Sakaguchi K. . 1994 J. Biol. Chem. 269: 23743–23749.

Download references

Acknowledgements

We thank Drs JH Pierce and M Yanagishita for support; Drs GD Aurbach and M Chedid for tumor RNA samples; and Q Chen for technical assistance.

Author information

Authors and Affiliations

Authors

Additional information

This article is a ‘United States Government Work’ paper as defined by the US Copyright Act.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakaguchi, K., Lorenzi, M., Matsushita, H. et al. Identification of a novel activated form of the keratinocyte growth factor receptor by expression cloning from parathyroid adenoma tissue. Oncogene 18, 5497–5505 (1999). https://doi.org/10.1038/sj.onc.1202947

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202947

Keywords

This article is cited by

Search

Quick links